Furthermore, it has been reported that IDO was expressed not only by tumour cells themselves, but also by dendritic cells in tumour-draining lymph nodes, and that melanoma patients with IDO-positive cells in lymph nodes had a poor clinical outcome (Munn et al, 2004). The gene discussed is IDO1; the disease is neoplasm.